# DOXIL (LIPOSOMAL)
> **NDA050718** · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 1995-11-17
## Drug
- **FDA Application Number:** NDA050718
- **Application type:** New Drug Application
- **Brand name:** DOXIL (LIPOSOMAL)
- **Generic name:** DOXORUBICIN HYDROCHLORIDE LIPOSOME
- **Active ingredients:** DOXORUBICIN HYDROCHLORIDE
- **Dosage form:** INJECTABLE, LIPOSOMAL
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** BAXTER HLTHCARE CORP
- **Manufacturer:** Baxter Healthcare Company
- **First approval:** 1995-11-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050718)
---
*AI Analytics · CC0 1.0*